Fujii H, Iida S, Tsugawa M, Gomi M, Moriwaki K, Tarui S
Second Department of Internal Medicine, Osaka University Medical School, Japan.
Endocrinology. 1990 Jan;126(1):26-30. doi: 10.1210/endo-126-1-26.
The effects of recombinant human somatomedin C/insulin-like growth factor (IGF-I) on the steroidogenic response of isolated rat adrenocortical cells to ACTH, forskolin, and (Bu)2cAMP were examined during short term incubations. The effect of IGF-I on cAMP production by cells stimulated with ACTH or forskolin was also examined. IGF-I inhibited ACTH-, forskolin-, and (Bu)2cAMP-induced corticosterone production in a concentration-dependent manner. IGF-I (30 ng/ml) also significantly inhibited ACTH-induced cAMP production. However, the peptide had no significant effect on forskolin-induced cAMP production. IGF-I suppressed ACTH-induced cAMP production both in the presence and absence of 3-isobutyl-1-methylxanthine, suggesting that IGF-I acts to inhibit the formation of cAMP rather than the stimulation of cAMP degradation. The observation that IGF-I inhibited steroidogenesis induced by (Bu)2cAMP strongly suggests that one site of inhibition is at some step(s) distal to cAMP formation. However, the inhibition of cAMP production after stimulation with ACTH also suggests a plasma membrane site of action for IGF-I in adrenocortical cells.
在短期培养过程中,研究了重组人生长调节素C/胰岛素样生长因子(IGF-I)对分离的大鼠肾上腺皮质细胞对促肾上腺皮质激素(ACTH)、福斯高林和二丁酰环磷腺苷((Bu)2cAMP)的类固醇生成反应的影响。还研究了IGF-I对用ACTH或福斯高林刺激的细胞产生环磷腺苷(cAMP)的影响。IGF-I以浓度依赖性方式抑制ACTH、福斯高林和(Bu)2cAMP诱导的皮质酮生成。IGF-I(30 ng/ml)也显著抑制ACTH诱导的cAMP生成。然而,该肽对福斯高林诱导的cAMP生成没有显著影响。在存在和不存在3-异丁基-1-甲基黄嘌呤的情况下,IGF-I均抑制ACTH诱导的cAMP生成,这表明IGF-I的作用是抑制cAMP的形成,而不是刺激cAMP的降解。IGF-I抑制(Bu)2cAMP诱导的类固醇生成这一观察结果强烈表明,一个抑制位点位于cAMP形成的某个或某些远端步骤。然而,ACTH刺激后cAMP生成的抑制也表明IGF-I在肾上腺皮质细胞中的作用位点在质膜。